-
Mashup Score: 1Oral Antivirals Can Benefit Hospitalized COVID-19 Patients - 2 year(s) ago
“Real-world” population study finds the oral antivirals authorized for non-hospitalized COVID-19 patients can benefit when started in the hospital.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet
-
Mashup Score: 0Postdoctoral Research Associate - 2 year(s) ago
The person to fill this position will be part of a team performing highly relevant translational research whose ultimate goal is to develop broadly active antiviral therapies. We aim to develop antivirals against coronavirus that we know about today and those that emerge in the future. The candidate will interact with both academic and industrial partners to achieve our goals. We are seeking…
Source: unc.peopleadmin.comCategories: Infectious Disease, Latest HeadlinesTweet-
#antivirals #postdoc #job posting https://t.co/JZbphIFlZG
-
-
Mashup Score: 1Postdoctoral Research Associate - 2 year(s) ago
The person to fill this position will be an essential part of a team performing highly relevant translational research whose ultimate goal is to better understand the molecular mechanisms of coronavirus pathogenesis and to develop broadly active vaccines and antiviral therapies to prevent and stop infection. We aim to develop medical counter measures against coronavirus that we know about today…
Source: unc.peopleadmin.comCategories: Infectious Disease, Latest HeadlinesTweet-
RT @timothysheahan: Fun! #postdocs on #coronavirus #pathogenesis and #antivirals apply here https://t.co/usDHjsGfM0
-
-
Mashup Score: 1
This is precisely the moment when the government should be preparing for the future.
Source: Washington PostCategories: Healthcare Professionals, Latest HeadlinesTweet-
đ âŠ@washingtonpostâ©. âThis is precisely the moment when the govt should be preparing for the future... A funding package for #vaccines, #antivirals, testing & more would be smart & forward-looking. https://t.co/NFYYHLQqFJ
-
-
Mashup Score: 1COVID-19 Will 'Not Become Endemic But Episodicâ - 2 year(s) ago
A clinician offers his perspective on how the virus is behaving and the role that vaccines and therapies will play.
Source: Contagion LiveCategories: Infectious Disease, Latest HeadlinesTweet-
What if #COVID19 doesn't become endemic and becomes episodic? A clinician weighs in on the behavior of the virus and the role #antivirals and #monoclonalantibodies will play. #IDtwitter https://t.co/zUtUrgqeJi
-
-
Mashup Score: 0
Three lab experiments show that Pfizer’s COVID-19 pill, Paxlovid, holds up well against the Omicron variant, but supplies are limited.
Source: Popular ScienceCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
How do #antivirals work and how could we best implement them? Learn more from Dr. Liz Duke in @PopSci https://t.co/6M96aHIvBa
-
-
Mashup Score: 2
Three lab experiments show that Pfizer’s COVID-19 pill, Paxlovid, holds up well against the Omicron variant, but supplies are limited.
Source: Popular ScienceCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
How do #antivirals work and how could we best implement them? Learn more from Dr. Liz Duke in @PopSci https://t.co/6M96aHIvBa
-
-
Mashup Score: 9
Three lab experiments show that Pfizer’s COVID-19 pill, Paxlovid, holds up well against the Omicron variant, but supplies are limited.
Source: Popular ScienceCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
How do #antivirals work and how could we best implement them? Learn more from Dr. Liz Duke in @PopSci https://t.co/6M96aHIvBa
-
-
Mashup Score: 0Two Antivirals No Better Than One for Severe Flu - 2 year(s) ago
Randomized trial finds no difference when adding baloxavir to standard antivirals
Source: www.medpagetoday.comCategories: Healthcare Professionals, Latest HeadlinesTweet-
Two #Antivirals No Better Than One for #SevereFlu â Randomized trial finds no difference when adding #Baloxavir to standard antivirals https://t.co/6qaUqIUPDK @medpagetoday #Influenza
-
-
Mashup Score: 0A Systematic Review on the Efficacy of Topical Acyclovir, Penciclovir, and Docosanol for the Treatment of Herpes Simplex Labialis - 2 year(s) ago
Herpes simplex labialis is a common skin condition caused by the herpes simplex virus. The prescription of antivirals for the treatment of herpes…
Source: European Medical JournalCategories: Dermatology, Latest HeadlinesTweet-
A Systematic Review on the Efficacy of Topical Acyclovir, Penciclovir, and Docosanol for the Treatment of Herpes Simplex Labialis. The figure shows a flowchart representing the literature search carried out during the review. https://t.co/xq3zCQwcQD #Lesions #Herpes #Antivirals
-
Oral #antivirals authorized to reduce risk of #COVID19 patients requiring hospitalization found to benefit hospitalized patients. https://t.co/6AdEQG1fcH